CSIA
BMY icon

Charles Schwab Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Charles Schwab Investment Advisory’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,840
Closed -$397K – 174
2019
Q3 		$397K Buy
+7,840
New +$368K ﹤0.01% 165

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Charles Schwab Investment Advisory's BMY Position: Q4 2019 in Review

Charles Schwab Investment Advisory sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 7,840 shares — an estimated $397K sold.

Charles Schwab Investment Advisory first reported a position in BMY in Q3 2019 and held it in 1 quarter. The position peaked at $397K in Q3 2019. 2,218 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Charles Schwab Investment Advisory reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
  • Charles Schwab Investment Advisory sold 7,840 Bristol-Myers Squibb shares in Q4 2019, an estimated $397K.
  • Charles Schwab Investment Advisory first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 1 quarter.
  • Charles Schwab Investment Advisory's Bristol-Myers Squibb position peaked at $397K in Q3 2019.
  • 2,218 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Charles Schwab Investment Advisory's 13F filing for Q4 2019, filed 13 Feb 2020.